{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:39:55Z","timestamp":1759963195644},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1097\/mbc.0b013e3283273529","type":"journal-article","created":{"date-parts":[[2009,5,21]],"date-time":"2009-05-21T10:31:12Z","timestamp":1242901872000},"page":"207-214","source":"Crossref","is-referenced-by-count":6,"title":["Is the inhibition of both clot-associated thrombin and factor Xa more clinically relevant than either one alone?"],"prefix":"10.1097","volume":"20","author":[{"given":"Sadia","family":"Meddahi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meyer Michel","family":"Samama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-7-20210203","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJM199201233260406","article-title":"The pathogenesis of coronary artery disease and the acute coronary syndromes","volume":"326","author":"Fuster","year":"1992","journal-title":"N Engl J Med"},{"key":"R2-7-20210203","first-page":"71","article-title":"Coagulation inflammation and myocardial dysfunction in unstable coronary artery disease and the influence of glycoprotein IIb\/IIIa inhibition and low molecular weight heparin","volume":"109","author":"James","year":"2004","journal-title":"Med Sci"},{"key":"R3-7-20210203","first-page":"366","article-title":"Haemostatic and inflammation markers in acute coronary syndromes and its relation ship with adverse cardiovascular events","volume":"76","author":"Diaz","year":"2006","journal-title":"Arch Cardio Res"},{"key":"R4-7-20210203","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1136\/bmj.308.6921.81","article-title":"I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet in various categories of patients. Antiplatelet trialists. Collaboration.","volume":"308","year":"1994","journal-title":"BMJ"},{"key":"R5-7-20210203","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/S0140-6736(00)02324-2","article-title":"Unfractionated heparin and low molecular heparin in acute coronary syndromes without ST elevation: a meta-analysis","volume":"355","author":"Eikelboom","year":"2000","journal-title":"Lancet"},{"key":"R6-7-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0038-1646366","article-title":"Role of thrombin in arterial thrombosis: implications for therapy","volume":"66","author":"Chesebro","year":"1991","journal-title":"Thromb Haemost"},{"key":"R7-7-20210203","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1073\/pnas.86.10.3619","article-title":"Fibrin monomer protects thrombin from inactivation heparin-antithrombin III: implications for heparin efficacy","volume":"86","author":"Hogg","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"R8-7-20210203","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1172\/JCI114723","article-title":"Clot bound thrombin is protected from inhibition heparin-antithrombin III but susceptible to inactivation by antithrombin III independent inhibitors","volume":"86","author":"Weitz","year":"1990","journal-title":"J Clin Invest"},{"key":"R9-7-20210203","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1161\/01.CIR.97.6.544","article-title":"Thrombin binds to soluble fibrin degradation products where it is protected from inhibition from inhibition by heparin-antithrombin III independent inhibitors","volume":"97","author":"Weitz","year":"1998","journal-title":"Circulation"},{"key":"R10-7-20210203","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1172\/JCI114272","article-title":"Binding of thrombin to subendothelial extacellular matrix: protection and expression of functional properties","volume":"84","author":"Bar-Shavit","year":"1989","journal-title":"J Clin Invest"},{"key":"R11-7-20210203","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJM199105303242206","article-title":"Heparin","volume":"324","author":"Hirsh","year":"1991","journal-title":"N Engl J Med"},{"key":"R12-7-20210203","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1056\/NEJM199709043371007","article-title":"Low molecular weight heparins","volume":"337","author":"Weitz","year":"1997","journal-title":"N Engl J Med"},{"key":"R13-7-20210203","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.thromres.2004.04.014","article-title":"Standard measurement of clot bound thrombin by using a chromogenic substrate for thrombin","volume":"114","author":"Meddahi","year":"2004","journal-title":"Thromb Res"},{"key":"R14-7-20210203","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/00001721-200001000-00006","article-title":"Pharmacologic modulation of thrombin generation associated to human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin","volume":"1","author":"Meddahi","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R15-7-20210203","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/01.mbc.0000161566.82011.94","article-title":"Determination of prothrombinase after adding human prothrombin to human clot: comparison of hirudin, activated factor II inhibitor, with DX9065a, an activated factor X inhibitor, on clot-associated thrombin and on prothrombin activation","volume":"16","author":"Meddahi","year":"2005","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R16-7-20210203","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1182\/blood.V74.3.1025.1025","article-title":"Evaluation of the inhibition by heparin and hirudin of coagulation activation during rtpa induced thrombolysis","volume":"74","author":"Mirshahi","year":"1989","journal-title":"Blood"},{"key":"R17-7-20210203","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(98)07332-2","article-title":"Effects of recombinant hirudin (Lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularization procedures in patients with acute myocardial infarction, refractory angina, and revascularisation procedures in patients with acute myocardial ischaemia without ST elevation: a randomised trial.","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"R18-7-20210203","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.thromres.2005.03.017","article-title":"Effects of the novel direct factor Xa inhibitor DX9065a on thrombin generation and inhibition among patients with stable atherosclerotic coronary disease","volume":"117","author":"Becker","year":"2006","journal-title":"Thromb Res"},{"key":"R19-7-20210203","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1055\/s-0037-1613294","article-title":"Antithrombotic effects of DX9065a, a direct factor Xa inhibitor: a comparative study in human versus low molecular weight heparin","volume":"88","author":"Shimbo","year":"2002","journal-title":"Thromb Haemost"},{"key":"R20-7-20210203","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1538-7836.2006.01830.x","article-title":"Inhibitors of blood coagulation factors Xa and IIa synergize to reduce thrombus weight and thrombin generation in vivo and in vitro","volume":"4","author":"Gould","year":"2006","journal-title":"Thromb Haemost"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00001721-200904000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:10:14Z","timestamp":1618035014000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001721-200904000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e3283273529","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2009,4]]}}}